Metadata
Title
Andreas Obermair
Category
general
UUID
24c5d61e4b59403b958274c99b8a417e
Source URL
https://about.uq.edu.au/experts/5973
Parent URL
https://about.uq.edu.au/experts/1976
Crawl Time
2026-03-11T07:32:14+00:00
Rendered Raw Markdown
# Andreas Obermair

**Source**: https://about.uq.edu.au/experts/5973
**Parent**: https://about.uq.edu.au/experts/1976

Professor

# Andreas Obermair

Email:
:   [a.obermair@uq.edu.au](mailto:a.obermair@uq.edu.au)

Phone:
:   [+61 7 334 66044](tel:+61 7 334 66044)

## Positions

NHMRC Leadership Fellow
:   UQ Centre for Clinical Research
:   Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Centre for Extracellular Vesicle Nanomedicine
:   Centre for Extracellular Vesicle Nanomedicine
:   Faculty of Health, Medicine and Behavioural Sciences

## Overview

### Background

Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and Buderim Private Hospital. He holds an Honorary title of Professor at UQ since 2006.

Professor Obermair is an internationally recognised leader in gynaecological oncology research and treatment and has lead the research team at QCGC Research since establishing it in 2003.

Read more
Read less

### Availability

Professor Andreas Obermair is:
:   Available for supervision

### Fields of research

[Biological Sciences](https://about.uq.edu.au/experts/search?research-field=4771)
[Biomedical and Clinical Sciences](https://about.uq.edu.au/experts/search?research-field=4760)
[Health Sciences](https://about.uq.edu.au/experts/search?research-field=4759)
[Medical microbiology](https://about.uq.edu.au/experts/search?research-field=4976)
[Oncology and carcinogenesis](https://about.uq.edu.au/experts/search?research-field=4892)

### Qualifications

- Doctoral Diploma of Medicine, International University Vienna
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists

### Research interests

- #### Clinical Trials

  Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias.
  Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.

  Read more
  Read less
- #### Translational Research

  The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.

  Read more
  Read less
- #### Quality of Life Research

  Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.

  Read more
  Read less
- #### Minimally Invasive Surgery

  In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery.
  Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.

  Read more
  Read less

### Research impacts

Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an ***NHMRC Investigator Fellowship Level 2*** (2021-25). The national impact of his research was recognised in 2017, when he was awarded ***Cancer Australia’s Jeannie Ferris Recognition Award (2017),*** for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the ***Board of the Cherish Foundation***, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.

Read more
Read less

## Works

[Search Professor Andreas Obermair’s works on UQ eSpace](http://espace.library.uq.edu.au/list/author_id/2895)

[All
(375)](https://about.uq.edu.au/experts-publication/5973/all)
[Journal Article
(329)](https://about.uq.edu.au/experts-publication/5973/4748)
[Other Outputs
(2)](https://about.uq.edu.au/experts-publication/5973/4749)
[Conference Publication
(43)](https://about.uq.edu.au/experts-publication/5973/4751)
[Book Chapter
(1)](https://about.uq.edu.au/experts-publication/5973/4752)

2026

Journal Article

##### Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial

Virili, Florencia, Obermair, Andreas, Sanjida, Saira, Nicklin, James L., Garrett, Andrea, Land, Russell, Tang, Amy, Campbell, Louise, Gebski, Val and Thomas, Paul (2026). Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial. International Journal of Gynecologic Cancer, 36 (1) 101854, 1-9. doi: 10.1136/ijgc-2024-005633

[Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial](https://espace.library.uq.edu.au/view/UQ:9636b8d)

2026

Journal Article

##### Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement

Salani, Ritu, Atallah, David, Fader, Amanda N., Frimer, Marina, Obermair, Andreas, Pareja, Rene and Huang, Marilyn (2026). Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecologic Oncology, 204, 109-117. doi: 10.1016/j.ygyno.2025.11.014

[Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement](https://espace.library.uq.edu.au/view/UQ:2815947)

2025

Journal Article

##### Efficacy of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: An Updated Systematic Review and Meta-analysis

King, Abigail, Harris, William, Campbell, Zara, Hazelton, Annabelle and Obermair, Andreas (2025). Efficacy of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: An Updated Systematic Review and Meta-analysis. International Journal of Gynecological Cancer, 36 (2) 102865, 102865. doi: 10.1016/j.ijgc.2025.102865

[Efficacy of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: An Updated Systematic Review and Meta-analysis](https://espace.library.uq.edu.au/view/UQ:4961ffb)

2025

Journal Article

##### Extracellular vesicles as biomarkers for endometrial cancer – a systematic review

Baxter, Eva, Nair, Soumyalekshmi, West, Zoe, Salomon, Carlos and Obermair, Andreas (2025). Extracellular vesicles as biomarkers for endometrial cancer – a systematic review. Translational Oncology, 62 102543, 1-10. doi: 10.1016/j.tranon.2025.102543

[Extracellular vesicles as biomarkers for endometrial cancer – a systematic review](https://espace.library.uq.edu.au/view/UQ:7ae0090)

2025

Journal Article

##### Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial

Baxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology, 50 (2), 259-266. doi: 10.1097/pas.0000000000002492

[Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial](https://espace.library.uq.edu.au/view/UQ:d4a0879)

2025

Journal Article

##### LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL

Baxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL. International Journal of Gynecological Cancer, 35 (11) 102239, 102239. doi: 10.1016/j.ijgc.2025.102239

[LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL](https://espace.library.uq.edu.au/view/UQ:edbf222)

2025

Journal Article

##### Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial

Al Ramadhani, Ruqaiya, Janda, Monika, Playdon, Mary and Obermair, Andreas (2025). Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial. Current Developments in Nutrition, 9 (12) 107572, 1-10. doi: 10.1016/j.cdnut.2025.107572

[Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial](https://espace.library.uq.edu.au/view/UQ:e9e3dcb)

2025

Journal Article

##### CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer

Cohen, P.A., Obermair, A., Gebski, V., King, M.T., Butow, P., Campbell, R., Bilic, S., Brand, A., Codde, J., Goh, J.C.H., Ives, A., Kiberu, A.D., Lawson, W., Mellon, A., McNally, O., Meniawy, T., Mileshkin, L., Morton, R., Webb, P. and Friedlander, M.L. (2025). CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer. Annals of Oncology, 36, S1650-S1539. doi: 10.1016/j.annonc.2025.08.1166

[CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer](https://espace.library.uq.edu.au/view/UQ:fcd7748)

2025

Journal Article

##### Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium

Nasioudis, Dimitrios, Wohlmuth, Christoph, Albright, Benjamin, McDonald, Megan, Wallace, Sumer, Glickman, Ariel, Do, Anthony, Mantia-Smaldone, Gina, Grassi, Tommaso, Fleming, Elaine, Tsibulak, Irina, Reis, Ricardo Dos, Cucinella, Giuseppe, Heredia, Fernando, Pereira, Augusto, Bogani, Giorgio, Buckingham, Lindsey, Baiocchi, Glauco, Mills, Kathryn, AlHilli, Mariam, Obermair, Andreas, Covens, Allan, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2025). Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium. Gynecologic Oncology, 200, 18-19. doi: 10.1016/j.ygyno.2025.03.075

[Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium](https://espace.library.uq.edu.au/view/UQ:2a913a2)

2025

Conference Publication

##### “The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations

Campbell, Rachel, Jeon, Megan, Friedlander, Michael, King, Madeleine T., Obermair, Andreas, Bilic, Sanela, Brand, Alison, Butow, Phyllis, Codde, Jim, Gebski, Val, Goh, Jeffrey C., Ives, Angela, Lawson, Wanda, McNally, Orla, Meniawy, Tarek, Mileshkin, Linda R., Morton, Rachael L., Webb, Penelope M., Yates, Patsy and Cohen, Paul Andrew (2025). “The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations. 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16\_suppl.12099

[“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations](https://espace.library.uq.edu.au/view/UQ:87daa8c)

2025

Journal Article

##### Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery

West, Simon, Jayasinghe, Dilki, Davie, Stacey and Obermair, Andreas (2025). Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery. International Journal of Gynecological Cancer, 35 (8) 101993, 101993. doi: 10.1016/j.ijgc.2025.101993

[Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery](https://espace.library.uq.edu.au/view/UQ:a369f5d)

2025

Other Outputs

##### The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery

Obermair, Helena, Dissanayake, D. M. Sadrushi L. and Obermair, Andreas (2025). The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery. Brisbane, QLD, Australia: The University of Queensland. doi: 10.14264/3ddf262

[The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery](https://espace.library.uq.edu.au/view/UQ:3ddf262)

2025

Journal Article

##### Subjective Assessment of Adnexal Masses Using Various Ultrasonographic Diagnostic Models: An Analysis of Interobserver Variability

Rizzuto, Ivana, Rezai, Shohreh, Lane, Annah, Prior, Marita, Robledo, Kristy P. and Obermair, Andreas (2025). Subjective Assessment of Adnexal Masses Using Various Ultrasonographic Diagnostic Models: An Analysis of Interobserver Variability. Australian & New Zealand Journal of Obstetrics & Gynaecology, 65 (6), 792-799. doi: 10.1111/ajo.70036

[Subjective Assessment of Adnexal Masses Using Various Ultrasonographic Diagnostic Models: An Analysis of Interobserver Variability](https://espace.library.uq.edu.au/view/UQ:1cfc1ee)

2025

Journal Article

##### Patterns of Care for Vulval Cancer Treatment: The Queensland Experience

Davie, S., Obermair, A. and West, Ze (2025). Patterns of Care for Vulval Cancer Treatment: The Queensland Experience. International Journal of Gynecological Cancer, 35 (7) 101956, 101956-7. doi: 10.1016/j.ijgc.2025.101956

[Patterns of Care for Vulval Cancer Treatment: The Queensland Experience](https://espace.library.uq.edu.au/view/UQ:40b81e9)

2025

Journal Article

##### Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers

Tuesley, Karen M., Spilsbury, Katrina, Pearson, Sallie-Anne, Donovan, Peter, Obermair, Andreas, Coory, Michael D., Ali, Sitwat, Pandeya, Nirmala, Stewart, Louise, Jordan, Susan J. and Webb, Penelope M. (2025). Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers. JNCI: Journal of the National Cancer Institute, 117 (5) djae282, 1046-1055. doi: 10.1093/jnci/djae282

[Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers](https://espace.library.uq.edu.au/view/UQ:d98feaa)

2025

Journal Article

##### A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma

Obermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer, 35 (4) 101644, 1-9. doi: 10.1016/j.ijgc.2025.101644

[A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma](https://espace.library.uq.edu.au/view/UQ:bf6c71f)

2025

Journal Article

##### Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer

Gersekowski, Kate, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2025). Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer. Journal of Epidemiology and Community Health, 79 (9), 684-690. doi: 10.1136/jech-2024-222687

[Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer](https://espace.library.uq.edu.au/view/UQ:ae98681)

2025

Journal Article

##### What is the true prognosis of T1a cervical cancer?

Ng, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, Van Lonkhuijzen, Luc R.c.w., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vít, Laky, Rene, Kim, Sarah K., Klát, Jaroslav, Kocián, Roman, Nemejcova, Kristyna and Cibula, David (2025). What is the true prognosis of T1a cervical cancer?. International Journal of Gynecological Cancer, 35 (2 s1) 100442, 100442. doi: 10.1016/j.ijgc.2024.100442

[What is the true prognosis of T1a cervical cancer?](https://espace.library.uq.edu.au/view/UQ:3a1f04a)

2025

Journal Article

##### Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644))

Obermair, Andreas, Gebski, Val, Goh, Jeffrey, Kuchel, Anna, Brand, Alison, Mak, Blossom, McNally, Orla, Baxter, Eva, Jobling, Thomas and Mileshkin, Linda (2025). Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644)). International Journal of Gynecological Cancer, 35 (9) 101961, 101961. doi: 10.1016/j.ijgc.2025.101961

[Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644))](https://espace.library.uq.edu.au/view/UQ:9e79801)

2025

Journal Article

##### The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims

Collings, Rachel, Potter, Christian, Gebski, Val, Janda, Monika and Obermair, Andreas (2025). The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims. American Journal of Obstetrics and Gynecology, 232 (1), 104.e1-104.e12. doi: 10.1016/j.ajog.2024.07.043

[The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims](https://espace.library.uq.edu.au/view/UQ:72a8ebc)

## Funding

### Current funding

- 2026 - 2030

  Towards evidence-supported precision surgery for gynaecological cancer

  NHMRC Investigator Grants

  [Open grant](https://about.uq.edu.au/experts/project/67427)
- 2025 - 2028

  The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer

  Cherish Women's Cancer Foundation

  [Open grant](https://about.uq.edu.au/experts/project/69688)
- 2025 - 2030

  Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)

  NHMRC Centres of Research Excellence

  [Open grant](https://about.uq.edu.au/experts/project/65725)
- 2025 - 2026

  The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer

  Cherish Women's Cancer Foundation

  [Open grant](https://about.uq.edu.au/experts/project/66769)
- 2024 - 2029

  The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detection

  NHMRC Partnership Projects

  [Open grant](https://about.uq.edu.au/experts/project/66269)
- 2024 - 2027

  Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Griffith University)

  Griffith University

  [Open grant](https://about.uq.edu.au/experts/project/67585)
- 2024 - 2029

  Salpingectomy with delayed oophorectomy to prevent ovarian cancer (TUBA WISP II) (MRFF ICTC Grant led by University of Melbourne)

  University of Melbourne

  [Open grant](https://about.uq.edu.au/experts/project/66297)
- 2024 - 2027

  EN.10 - A Phase II study of adjuvant therapy in pole-mutated and p53-wildtype/NSWP early stage endometrial cancer (RAINBO BLUE & TAPER)

  Australia New Zealand Gynaecological Oncology Group

  [Open grant](https://about.uq.edu.au/experts/project/66382)
- 2024 - 2028

  ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)

  NHMRC Clinical Trials and Cohort Studies Grants

  [Open grant](https://about.uq.edu.au/experts/project/60253)
- 2023 - 2028

  Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer

  Research Donation Generic

  [Open grant](https://about.uq.edu.au/experts/project/63787)
- 2022 - 2026

  A non-surgical alternative to hysterectomy for the treatment of endometrial cancer

  NHMRC Partnership Projects

  [Open grant](https://about.uq.edu.au/experts/project/52945)
- 2010 - 2026

  QCOG (Data Manager Grant)

  Cancer Council Queensland

  [Open grant](https://about.uq.edu.au/experts/project/12185)

View all 12 current funded projects
View less

### Past funding

- 2024

  Moving without fear when living with stoma: A consumer-led physical activity study

  NHMRC MRFF PPHR - Consumer Led Research

  [Open grant](https://about.uq.edu.au/experts/project/63006)
- 2024 - 2025

  Queensland Centre for Gynaecological Cancer's NODE Study

  Gynaecological Cancer Research, Education and Development Society Limited Research Grant

  [Open grant](https://about.uq.edu.au/experts/project/64872)
- 2024

  Improving quality of life for vulvar cancer patients through non-invasive interventions

  Metro North Hospital and Health Service

  [Open grant](https://about.uq.edu.au/experts/project/66380)
- 2021 - 2024

  MOST (Measure of Ovarian Symptoms and Treatment concerns)

  St John of God Healthcare Inc

  [Open grant](https://about.uq.edu.au/experts/project/52236)
- 2021 - 2025

  Creating treatment options for endometrial cancer through high-level clinical trials

  NHMRC Investigator Grants

  [Open grant](https://about.uq.edu.au/experts/project/42246)
- 2020 - 2022

  A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)

  Cherish Women's Cancer Foundation

  [Open grant](https://about.uq.edu.au/experts/project/43011)
- 2020 - 2024

  A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).

  Griffith University

  [Open grant](https://about.uq.edu.au/experts/project/42887)
- 2020 - 2023

  Implementing non-surgical options for endometrial cancer treatment into clinical practice

  ICON Cancer Care

  [Open grant](https://about.uq.edu.au/experts/project/41226)
- 2020 - 2021

  A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)

  Metro North Hospital and Health Service

  [Open grant](https://about.uq.edu.au/experts/project/38667)
- 2019 - 2020

  feMMe Long Term Follow-Up study

  ASGO Research Grants

  [Open grant](https://about.uq.edu.au/experts/project/47488)
- 2019 - 2020

  A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)

  Gynaecological Cancer Research, Education and Development Society Limited Research Grant

  [Open grant](https://about.uq.edu.au/experts/project/38363)
- 2017 - 2020

  The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial

  NHMRC Partnership Projects

  [Open grant](https://about.uq.edu.au/experts/project/33119)
- 2017 - 2018

  Transforming surgical practice through innovation IMAGINE

  Metro North Hospital and Health Service

  [Open grant](https://about.uq.edu.au/experts/project/32834)
- 2017 - 2021

  The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)

  Queensland University of Technology

  [Open grant](https://about.uq.edu.au/experts/project/35073)
- 2017 - 2021

  The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)

  Queensland Institute of Medical Research

  [Open grant](https://about.uq.edu.au/experts/project/31474)
- 2016 - 2018

  Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/28287)
- 2016

  QCOG 2016

  Cancer Council Queensland

  [Open grant](https://about.uq.edu.au/experts/project/28402)
- 2015 - 2019

  Cherish women's cancer foundation research fellow funding

  Cherish Women's Cancer Foundation

  [Open grant](https://about.uq.edu.au/experts/project/27081)
- 2015 - 2022

  ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)

  University of Sydney

  [Open grant](https://about.uq.edu.au/experts/project/26124)
- 2015 - 2018

  The fEMMe trial

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/26441)
- 2015 - 2016

  In Memory of Denise Marcella Collins

  Research Donation Generic

  [Open grant](https://about.uq.edu.au/experts/project/26919)
- 2015 - 2016

  Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer

  Royal Brisbane and Women's Hospital

  [Open grant](https://about.uq.edu.au/experts/project/23446)
- 2015 - 2019

  Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)

  University of Sydney

  [Open grant](https://about.uq.edu.au/experts/project/26721)
- 2014 - 2015

  A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium

  Royal Brisbane and Women's Hospital Foundation

  [Open grant](https://about.uq.edu.au/experts/project/22175)
- 2014 - 2015

  Barriers of the uptake of laparoscopic hysterectomy

  Australian Centre for Health Services Innovation

  [Open grant](https://about.uq.edu.au/experts/project/21494)
- 2014 - 2015

  A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium

  Australia New Zealand Gynaecological Oncology Group

  [Open grant](https://about.uq.edu.au/experts/project/26829)
- 2014 - 2015

  Prophylactic surgery and breast cancer

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/21325)
- 2013 - 2020

  ACRF Molecular Oncology Translational Imaging Facility (MOTIF)

  Australian Cancer Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/21141)
- 2013 - 2016

  Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)

  Queensland University of Technology

  [Open grant](https://about.uq.edu.au/experts/project/20465)
- 2013

  A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium

  Royal Brisbane and Women's Hospital

  [Open grant](https://about.uq.edu.au/experts/project/15985)
- 2013

  QCOG 2013 (Data Manager Grants)

  Cancer Council Queensland

  [Open grant](https://about.uq.edu.au/experts/project/20323)
- 2012 - 2023

  In Memory of Jan Sanders and other philanthropic donations

  Research Donation Generic

  [Open grant](https://about.uq.edu.au/experts/project/14990)
- 2012 - 2013

  LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study

  Queensland University of Technology

  [Open grant](https://about.uq.edu.au/experts/project/14710)
- 2012 - 2013

  The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer

  Royal Brisbane and Women's Hospital

  [Open grant](https://about.uq.edu.au/experts/project/15254)
- 2011 - 2012

  HE 4 Collaborative Study

  Abbott Australasia Pty Ltd

  [Open grant](https://about.uq.edu.au/experts/project/13430)
- 2011

  LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study

  Royal Brisbane and Women's Hospital

  [Open grant](https://about.uq.edu.au/experts/project/13467)
- 2011 - 2012

  Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer

  Wesley Merdical Research

  [Open grant](https://about.uq.edu.au/experts/project/11562)
- 2010 - 2023

  A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)

  University of Texas M.D. Anderson Cancer Centre

  [Open grant](https://about.uq.edu.au/experts/project/13626)
- 2010 - 2013

  Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/11859)
- 2010 - 2013

  Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/11860)
- 2009 - 2011

  National Gynaecological Cancers Service Delivery and Resources Framework

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/11911)
- 2009 - 2012

  Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer

  Mayne Bequest Fund

  [Open grant](https://about.uq.edu.au/experts/project/11944)
- 2009 - 2012

  A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer

  University of Texas M.D. Anderson Cancer Centre

  [Open grant](https://about.uq.edu.au/experts/project/10972)
- 2009 - 2010

  Cancer Clinical Trial Data Management Grant 2009

  Cancer Council Queensland

  [Open grant](https://about.uq.edu.au/experts/project/10993)
- 2009 - 2010

  Post-operative enteral nutrition among patients with ovarian cancer

  Gallipoli Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/10968)
- 2009

  Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/11784)
- 2009 - 2010

  Prospective evaluation of lymphoedema among patients with gynaecological cancer

  Gallipoli Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/10966)
- 2008 - 2011

  Prospective evaluation of lymphoedema among patients with gynaecological cancer

  Wesley Merdical Research

  [Open grant](https://about.uq.edu.au/experts/project/10845)
- 2008 - 2011

  Prospective evaluation of lymphoedema among patients with gynaecological cancer

  Cancer Australia

  [Open grant](https://about.uq.edu.au/experts/project/10065)
- 2008 - 2009

  LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/10241)
- 2008

  Cancer Clinical Trial Data Management grant 2008

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/9933)
- 2008

  Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/10064)
- 2007 - 2009

  Total Laparoscopic hysterectomy for Endometrial Cancer

  Queensland Health Smart Health Research Grant

  [Open grant](https://about.uq.edu.au/experts/project/9031)
- 2007

  Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/9033)
- 2007

  LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/9072)
- 2007 - 2009

  Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer

  NHMRC Project Grant

  [Open grant](https://about.uq.edu.au/experts/project/19685)
- 2006

  Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/8299)
- 2006

  LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/8694)
- 2006 - 2007

  Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/8300)
- 2005 - 2006

  Clinical Trial Data Manager

  Queensland Cancer Fund

  [Open grant](https://about.uq.edu.au/experts/project/7387)
- 2005 - 2006

  Start-up Grant

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/8120)
- 2004 - 2007

  Gynaecological Cancer Society Research Grants

  Gynaecological Cancer Society

  [Open grant](https://about.uq.edu.au/experts/project/7050)
- 2004

  Mismatch repair gene defects in endometrial cancer patients less than 50 years of age

  Royal Brisbane & Women's Hospital Research Foundation

  [Open grant](https://about.uq.edu.au/experts/project/7027)

View all 63 past funded projects
View less

## Supervision

### Availability

Professor Andreas Obermair is:
:   Available for supervision

Looking for a supervisor? Read our advice on [how to choose a supervisor](https://study.uq.edu.au/study-options/phd-mphil-professional-doctorate/how-to-choose-a-supervisor).

### Available projects

- #### [Improving Quality of Survival for Women with Gynaecological Cancer](https://study.uq.edu.au/study-options/phd-mphil-professional-doctorate/projects/improving-quality-survival-women-gynaecological-cancer)

  - Focus on improving quality of life, health & function during & after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.

  Read more
  Read less

### Supervision history

#### Current supervision

- Doctor Philosophy

  ##### Advanced methods for biomarker informed endometrial cancer

  Principal Advisor

  Other advisors:
  [Dr Eva Baxter](https://about.uq.edu.au/experts/20108), [Dr Zoe West](https://about.uq.edu.au/experts/41071), [Professor Andrew Martin](https://about.uq.edu.au/experts/42729)
- Master Philosophy

  ##### Patterns of care in endometrial cancer management in Queensland: a retrospective analysis.

  Principal Advisor

  Other advisors:
  [Dr Eva Baxter](https://about.uq.edu.au/experts/20108)

#### Completed supervision

- 2014

  Doctor Philosophy

  ##### [Hereditary endometrial cancer: Improving identification and referral of patients with suspected Lynch syndrome](https://espace.library.uq.edu.au/view/UQ:327684)

  Principal Advisor

  Other advisors:
  [Honorary Professor Amanda Spurdle](https://about.uq.edu.au/experts/4277), [Associate Professor Lisa Fitzgerald](https://about.uq.edu.au/experts/1976)
- 2008

  Doctor Philosophy

  ##### [Nutritional status of patients with gynaecological cancer -](https://espace.library.uq.edu.au/view/UQ:155662)

  Joint Principal Advisor

  Other advisors:
  [Emeritus Professor Geoffrey Cleghorn](https://about.uq.edu.au/experts/262)
- 2026

  Doctor Philosophy

  ##### [Diet quality, lifestyle, and metabolic profiles in women with endometrial cancer and their impact on health-related outcomes](https://espace.library.uq.edu.au/view/UQ:f4a19cb)

  Associate Advisor

  Other advisors:
  [Professor Monika Janda](https://about.uq.edu.au/experts/11560)
- 2009

  Doctor Philosophy

  ##### [Biology of CA125 in ovarian cancer biology](https://espace.library.uq.edu.au/view/UQ:165420)

  Associate Advisor

  Other advisors:
  [Honorary Professor Michael McGuckin](https://about.uq.edu.au/experts/3135)

## Media

### Enquiries

For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:

[communications@uq.edu.au](mailto:communications@uq.edu.au)

## External profiles

- [ORCID](https://orcid.org/0000-0003-2199-1117)
- [ResearcherID](https://www.webofscience.com/wos/author/record/B-1175-2009)
- [Scopus](https://www.scopus.com/authid/detail.uri?authorId=55403869400)

## Personal links

- [Personal profile](https://gyncan.org)

## Social media

- [Linkedin](https://www.linkedin.com/in/andreas-obermair-a19607b/)
- [X](https://twitter.com/AndreasObermair)
- [Facebook](https://www.facebook.com/andreas.obermair.7)

Log in to Academic Portal to update your profile

[Update my profile](https://academicportal.app.uq.edu.au/profile/)